Xenetic Biosciences

Last updated: 13.02.2014

Address: 1 Royal College St ,London, Greater London NW1 0SB, UK

Tel: +44(0) 20 7691 4906

Web: http://www.xeneticbio.com/

Company description

Xenetic is a leading UK based biopharmaceutical company providing leading edge expertise in the development of a whole new generation of drugs and vaccines.

Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas.

We are also actively developing our own pipeline of next generation biotherapeutics based on our proprietary PolyXen andImuXen platform technologies.

Products and services

Xenetic’s biopharmaceutical pipeline contains a range of product candidates which are currently under development either in-house or with biotechnology and pharmaceutical partners. The products in Xenetic’s pipeline have a multi-billion dollar market potential.
Pipeline products are based on Xenetic’s proprietary drug and vaccine delivery technologies and have been developed to offer improved performance and delivery characteristics. Xenetic’s unique delivery technologies are also able to create new high-value, differentiated proprietary products from off-patent actives.

Xenetic has established a range of partnerships with major US, European, Russian and Asian biotechnology and pharmaceutical companies to develop new protein therapeutics and vaccines. Click here to learn more about the work we do with our partners.


We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here